{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T19:03:25Z","timestamp":1786475005882,"version":"build-2736575974"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,10,23]],"date-time":"2020-10-23T00:00:00Z","timestamp":1603411200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,10,23]],"date-time":"2020-10-23T00:00:00Z","timestamp":1603411200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["ICMx"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Purpose<\/jats:title>\n<jats:p>Existing clinical practice guidelines support the use of neuromuscular blocking agents (NMBA) in acute respiratory distress syndrome (ARDS); however, a recent large randomized clinical trial (RCT) has questioned this practice. Therefore, we updated a previous systematic review to determine the efficacy and safety of NMBAs in ARDS.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>We searched MEDLINE, EMBASE (October 2012 to July 2019), the Cochrane (Central) database, and clinical trial registries (<jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/clinicaltrials.gov\">ClinicalTrials.gov<\/jats:ext-link>, ISRCTN Register, and WHO ICTRP) for RCTs comparing the effects of NMBA as a continuous infusion versus placebo or no NMBA infusion (but allowing intermittent NMBA boluses) on patient-important outcomes for adults with ARDS. Two independent reviewers assessed the methodologic quality of the primary studies and abstracted data.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>Seven RCTs, including four new RCTs, met eligibility criteria for this review. These trials enrolled 1598 patients with moderate to severe ARDS at centers in the USA, France, and China. All trials assessed short-term continuous infusions of cisatracurium or vecuronium. The pooled estimate for mortality outcomes showed significant statistical heterogeneity, which was only explained by a subgroup analysis by depth of sedation in the control arm. A continuous NMBA infusion did not improve mortality when compared to a light sedation strategy with no NMBA infusion (relative risk [RR] 0.99; 95% CI 0.86\u20131.15; moderate certainty; <jats:italic>P =<\/jats:italic> 0.93). On the other hand, continuous NMBA infusion reduced mortality when compared to deep sedation with as needed NMBA boluses (RR 0.71; 95% CI 0.57\u20130.89; low certainty; <jats:italic>P =<\/jats:italic> 0.003). Continuous NMBA infusion reduced the rate of barotrauma (RR 0.55; 95% CI 0.35\u20130.85, moderate certainty; <jats:italic>P<\/jats:italic> = 0.008) across eligible trials, but the effect on ventilator-free days, duration of mechanical ventilation, and ICU-acquired weakness was uncertain.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusions<\/jats:title>\n<jats:p>Inconsistency in study methods and findings precluded the pooling of all trials for mortality. In a pre-planned sensitivity analysis, the impact of NMBA infusion on mortality depends on the strategy used in the control arm, showing reduced mortality when compared to deep sedation, but no effect on mortality when compared to lighter sedation. In both situations, a continuous NMBA infusion may reduce the risk of barotrauma, but the effects on other patient-important outcomes remain unclear. Future research, including an individual patient data meta-analysis, could help clarify some of the observed findings in this updated systematic review.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s40635-020-00348-6","type":"journal-article","created":{"date-parts":[[2020,10,23]],"date-time":"2020-10-23T07:02:53Z","timestamp":1603436573000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":41,"title":["Neuromuscular blocking agents in acute respiratory distress syndrome: updated systematic review and meta-analysis of randomized trials"],"prefix":"10.1186","volume":"8","author":[{"given":"Nehal","family":"Tarazan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moayad","family":"Alshehri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sameer","family":"Sharif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zainab","family":"Al Duhailib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morten Hylander","family":"M\u00f8ller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilie","family":"Belley-Cote","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Alshahrani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Centofanti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauralyn","family":"McIntyre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bandar","family":"Baw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maureen","family":"Meade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8076-9626","authenticated-orcid":false,"given":"Waleed","family":"Alhazzani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"for the GUIDE Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,10,23]]},"reference":[{"key":"348_CR1","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1056\/NEJMra1608077","volume":"377","author":"BT Thompson","year":"2017","unstructured":"Thompson BT, Chambers RC, Liu KD (2017) Acute respiratory distress syndrome. N Engl J Med 377:562\u2013572","journal-title":"N Engl J Med"},{"key":"348_CR2","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1001\/jama.2016.0291","volume":"315","author":"G Bellani","year":"2016","unstructured":"Bellani G, Laffey JG, Pham T, Fan E, Brochard L, Esteban A, Gattinoni L, van Haren F, Larsson A, DF MA, Ranieri M, Rubenfeld G, Thompson BT, Wrigge H, Slutsky AS, Pesenti A, Investigators LS, Group ET (2016) Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries. JAMA 315:788\u2013800","journal-title":"JAMA"},{"key":"348_CR3","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1007\/s00134-016-4321-8","volume":"42","author":"MS Herridge","year":"2016","unstructured":"Herridge MS, Moss M, Hough CL, Hopkins RO, Rice TW, Bienvenu OJ, Azoulay E (2016) Recovery and outcomes after the acute respiratory distress syndrome (ARDS) in patients and their family caregivers. Intensive Care Med 42:725\u2013738","journal-title":"Intensive Care Med"},{"key":"348_CR4","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1056\/NEJMoa1011802","volume":"364","author":"MS Herridge","year":"2011","unstructured":"Herridge MS, Tansey CM, Matte A, Tomlinson G, Diaz-Granados N, Cooper A, Guest CB, Mazer CD, Mehta S, Stewart TE, Kudlow P, Cook D, Slutsky AS, Cheung AM, Canadian Critical Care Trials G (2011) Functional disability 5 years after acute respiratory distress syndrome. N Engl J Med 364:1293\u20131304","journal-title":"N Engl J Med"},{"key":"348_CR5","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1056\/NEJM200005043421801","volume":"342","author":"RG Brower","year":"2000","unstructured":"Acute Respiratory Distress Syndrome N, Brower RG, Matthay MA, Morris A, Schoenfeld D, Thompson BT, Wheeler A (2000) Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med 342:1301\u20131308","journal-title":"N Engl J Med"},{"key":"348_CR6","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1001\/jama.2010.218","volume":"303","author":"M Briel","year":"2010","unstructured":"Briel M, Meade M, Mercat A, Brower RG, Talmor D, Walter SD, Slutsky AS, Pullenayegum E, Zhou Q, Cook D, Brochard L, Richard JC, Lamontagne F, Bhatnagar N, Stewart TE, Guyatt G (2010) Higher vs lower positive end-expiratory pressure in patients with acute lung injury and acute respiratory distress syndrome: systematic review and meta-analysis. JAMA 303:865\u2013873","journal-title":"JAMA"},{"key":"348_CR7","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.1056\/NEJMoa1214103","volume":"368","author":"C Guerin","year":"2013","unstructured":"Guerin C, Reignier J, Richard JC, Beuret P, Gacouin A, Boulain T, Mercier E, Badet M, Mercat A, Baudin O, Clavel M, Chatellier D, Jaber S, Rosselli S, Mancebo J, Sirodot M, Hilbert G, Bengler C, Richecoeur J, Gainnier M, Bayle F, Bourdin G, Leray V, Girard R, Baboi L, Ayzac L, Group PS (2013) Prone positioning in severe acute respiratory distress syndrome. N Engl J Med 368:2159\u20132168","journal-title":"N Engl J Med"},{"key":"348_CR8","doi-asserted-by":"publisher","first-page":"R43","DOI":"10.1186\/cc12557","volume":"17","author":"W Alhazzani","year":"2013","unstructured":"Alhazzani W, Alshahrani M, Jaeschke R, Forel JM, Papazian L, Sevransky J, Meade MO (2013) Neuromuscular blocking agents in acute respiratory distress syndrome: a systematic review and meta-analysis of randomized controlled trials. Crit Care 17:R43","journal-title":"Crit Care"},{"key":"348_CR9","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1056\/NEJMoa1005372","volume":"363","author":"L Papazian","year":"2010","unstructured":"Papazian L, Forel JM, Gacouin A, Penot-Ragon C, Perrin G, Loundou A, Jaber S, Arnal JM, Perez D, Seghboyan JM, Constantin JM, Courant P, Lefrant JY, Guerin C, Prat G, Morange S, Roch A, Investigators AS (2010) Neuromuscular blockers in early acute respiratory distress syndrome. N Engl J Med 363:1107\u20131116","journal-title":"N Engl J Med"},{"key":"348_CR10","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1056\/NEJMe1007136","volume":"363","author":"AS Slutsky","year":"2010","unstructured":"Slutsky AS (2010) Neuromuscular blocking agents in ARDS. N Engl J Med 363:1176\u20131180","journal-title":"N Engl J Med"},{"key":"348_CR11","doi-asserted-by":"publisher","first-page":"1818","DOI":"10.1513\/AnnalsATS.201612-1042OC","volume":"14","author":"EH Duan","year":"2017","unstructured":"Duan EH, Adhikari NKJ, D'Aragon F, Cook DJ, Mehta S, Alhazzani W, Goligher E, Charbonney E, Arabi YM, Karachi T, Turgeon AF, Hand L, Zhou Q, Austin P, Friedrich J, Lamontagne F, Lauzier F, Patel R, Muscedere J, Hall R, Aslanian P, Piraino T, Albert M, Bagshaw SM, Jacka M, Wood G, Henderson W, Dorscheid D, Ferguson ND, Meade MO, Canadian Critical Care Trials G (2017) Management of acute respiratory distress syndrome and refractory hypoxemia. A multicenter observational study. Ann Am Thorac Soc 14:1818\u20131826","journal-title":"Ann Am Thorac Soc"},{"key":"348_CR12","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.1056\/NEJMoa1901686","volume":"380","author":"M Moss","year":"2019","unstructured":"National Heart L, Blood Institute PCTN, Moss M, Huang DT, Brower RG, Ferguson ND, Ginde AA, Gong MN, Grissom CK, Gundel S, Hayden D, Hite RD, Hou PC, Hough CL, Iwashyna TJ, Khan A, Liu KD, Talmor D, Thompson BT, Ulysse CA, Yealy DM, Angus DC (2019) Early neuromuscular blockade in the acute respiratory distress syndrome. N Engl J Med 380:1997\u20132008","journal-title":"N Engl J Med"},{"key":"348_CR13","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1007\/s00134-019-05786-9","volume":"45","author":"W Alhazzani","year":"2019","unstructured":"Alhazzani W, M\u00f8ller MH, Belley-Cote E, Citerio G (2019) Intensive care medicine rapid practice guidelines (ICM-RPG): paving the road of the future. Intensive Care Med 45:1639\u20131641","journal-title":"Intensive Care Med"},{"key":"348_CR14","doi-asserted-by":"publisher","first-page":"2873","DOI":"10.1007\/s10461-016-1350-9","volume":"20","author":"CC Hoff","year":"2016","unstructured":"Hoff CC, Campbell CK, Chakravarty D, Darbes LA (2016) Relationship-based predictors of sexual risk for HIV among MSM couples: a systematic review of the literature. AIDS Behav 20:2873\u20132892","journal-title":"AIDS Behav"},{"key":"348_CR15","first-page":"343","volume":"d5928","author":"JP Higgins","year":"2011","unstructured":"Higgins JP, Altman DG, Gotzsche PC, Juni P, Moher D, Oxman AD, Savovic J, Schulz KF, Weeks L, Sterne JA, Cochrane Bias Methods G, Cochrane statistical methods G (2011) The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ d5928:343","journal-title":"BMJ"},{"key":"348_CR16","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","volume":"7","author":"R DerSimonian","year":"1986","unstructured":"DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7:177\u2013188","journal-title":"Control Clin Trials"},{"key":"348_CR17","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","volume":"315","author":"M Egger","year":"1997","unstructured":"Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315:629\u2013634","journal-title":"BMJ"},{"key":"348_CR18","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","volume":"336","author":"GH Guyatt","year":"2008","unstructured":"Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, Schunemann HJ, Group GW (2008) GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 336:924\u2013926","journal-title":"BMJ"},{"key":"348_CR19","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1097\/01.CCM.0000104114.72614.BC","volume":"32","author":"M Gainnier","year":"2004","unstructured":"Gainnier M, Roch A, Forel JM, Thirion X, Arnal JM, Donati S, Papazian L (2004) Effect of neuromuscular blocking agents on gas exchange in patients presenting with acute respiratory distress syndrome. Crit Care Med 32:113\u2013119","journal-title":"Crit Care Med"},{"key":"348_CR20","doi-asserted-by":"publisher","first-page":"2749","DOI":"10.1097\/01.CCM.0000239435.87433.0D","volume":"34","author":"JM Forel","year":"2006","unstructured":"Forel JM, Roch A, Marin V, Michelet P, Demory D, Blache JL, Perrin G, Gainnier M, Bongrand P, Papazian L (2006) Neuromuscular blocking agents decrease inflammatory response in patients presenting with acute respiratory distress syndrome. Crit Care Med 34:2749\u20132757","journal-title":"Crit Care Med"},{"key":"348_CR21","first-page":"325","volume":"26","author":"G Lyu","year":"2014","unstructured":"Lyu G, Wang X, Jiang W, Cai T, Zhang Y (2014) Clinical study of early use of neuromuscular blocking agents in patients with severe sepsis and acute respiratory distress syndrome. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue 26:325\u2013329","journal-title":"Zhonghua Wei Zhong Bing Ji Jiu Yi Xue"},{"key":"348_CR22","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1007\/s00134-016-4653-4","volume":"43","author":"C Guervilly","year":"2017","unstructured":"Guervilly C, Bisbal M, Forel JM, Mechati M, Lehingue S, Bourenne J, Perrin G, Rambaud R, Adda M, Hraiech S, Marchi E, Roch A, Gainnier M, Papazian L (2017) Effects of neuromuscular blockers on transpulmonary pressures in moderate to severe acute respiratory distress syndrome. Intensive Care Med 43:408\u2013418","journal-title":"Intensive Care Med"},{"key":"348_CR23","first-page":"973","volume":"28","author":"ZLJ Rao","year":"2016","unstructured":"Rao ZLJ, Ma Y, Li X, Xue J, Tian L, Zhou W, Kuang Y (2016) To retain spontaneous breathing or eliminate spontaneous breathing with neuromuscular blockers in acute respiratory distress syndrome patients? Chinese Critical Care Medicine 28:973\u2013977","journal-title":"Chinese Critical Care Medicine"},{"key":"348_CR24","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1097\/CCM.0000000000002885","volume":"46","author":"RJ Stephens","year":"2018","unstructured":"Stephens RJ, Dettmer MR, Roberts BW, Ablordeppey E, Fowler SA, Kollef MH, Fuller BM (2018) Practice patterns and outcomes associated with early sedation depth in mechanically ventilated patients: a systematic review and meta-analysis. Crit Care Med 46:471\u2013479","journal-title":"Crit Care Med"},{"key":"348_CR25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0227664","volume":"15","author":"Y Hua","year":"2020","unstructured":"Hua Y, Ou X, Li Q, Zhu T (2020) Neuromuscular blockers in the acute respiratory distress syndrome: a meta-analysis. PLoS One 15:e0227664","journal-title":"PLoS One"},{"key":"348_CR26","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1164\/rccm.201604-0748CP","volume":"195","author":"T Yoshida","year":"2017","unstructured":"Yoshida T, Fujino Y, Amato MB, Kavanagh BP (2017) Fifty years of research in ARDS. Spontaneous breathing during mechanical ventilation. Risks, mechanisms, and management. Am J Respir Crit Care Med 195:985\u2013992","journal-title":"Am J Respir Crit Care Med"},{"key":"348_CR27","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1097\/CCM.0b013e3182451c40","volume":"40","author":"T Yoshida","year":"2012","unstructured":"Yoshida T, Uchiyama A, Matsuura N, Mashimo T, Fujino Y (2012) Spontaneous breathing during lung-protective ventilation in an experimental acute lung injury model: high transpulmonary pressure associated with strong spontaneous breathing effort may worsen lung injury. Crit Care Med 40:1578\u20131585","journal-title":"Crit Care Med"},{"key":"348_CR28","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1007\/s00134-016-4423-3","volume":"42","author":"JR Beitler","year":"2016","unstructured":"Beitler JR, Sands SA, Loring SH, Owens RL, Malhotra A, Spragg RG, Matthay MA, Thompson BT, Talmor D (2016) Quantifying unintended exposure to high tidal volumes from breath stacking dyssynchrony in ARDS: the BREATHE criteria. Intensive Care Med 42:1427\u20131436","journal-title":"Intensive Care Med"},{"key":"348_CR29","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1007\/s00134-002-1508-y","volume":"28","author":"F Lagneau","year":"2002","unstructured":"Lagneau F, D'Honneur G, Plaud B, Mantz J, Gillart T, Duvaldestin P, Marty J, Clyti N, Pourriat JL (2002) A comparison of two depths of prolonged neuromuscular blockade induced by cisatracurium in mechanically ventilated critically ill patients. Intensive Care Med 28:1735\u20131741","journal-title":"Intensive Care Med"},{"key":"348_CR30","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1007\/BF01649314","volume":"68","author":"E Weber","year":"1990","unstructured":"Weber E (1990) Clinical testing of new drugs in psychiatry. Klin Wochenschr 68:1085\u20131086","journal-title":"Klin Wochenschr"},{"key":"348_CR31","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1016\/S1474-4422(11)70178-8","volume":"10","author":"N Latronico","year":"2011","unstructured":"Latronico N, Bolton CF (2011) Critical illness polyneuropathy and myopathy: a major cause of muscle weakness and paralysis. Lancet Neurol 10:931\u2013941","journal-title":"Lancet Neurol"},{"key":"348_CR32","doi-asserted-by":"publisher","first-page":"2281","DOI":"10.1097\/00003246-200112000-00008","volume":"29","author":"MA de Letter","year":"2001","unstructured":"de Letter MA, Schmitz PI, Visser LH, Verheul FA, Schellens RL, Op de Coul DA, van der Meche FG (2001) Risk factors for the development of polyneuropathy and myopathy in critically ill patients. Crit Care Med 29:2281\u20132286","journal-title":"Crit Care Med"},{"key":"348_CR33","first-page":"3819","volume":"99","author":"ZW Gao","year":"2019","unstructured":"Gao ZW, Zhao HM, Sun QS, Sun H, Huang YZ, Zheng P (2019) Systematic evaluation of neuromuscular blocking agents on prognosis of patients with moderate to severe acute respiratory distress syndrome. Zhonghua Yi Xue Za Zhi 99:3819\u20133825","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"348_CR34","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s13054-020-2765-2","volume":"24","author":"W Chang","year":"2020","unstructured":"Chang W, Sun Q, Peng F, Xie J, Qiu H, Yang Y (2020) Validation of neuromuscular blocking agent use in acute respiratory distress syndrome: a meta-analysis of randomized trials. Crit Care 24:54","journal-title":"Crit Care"},{"key":"348_CR35","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1164\/rccm.201706-1132OC","volume":"197","author":"PD Sottile","year":"2018","unstructured":"Sottile PD, Kiser TH, Burnham EL, Ho PM, Allen RR, Vandivier RW, Moss M, Colorado Pulmonary Outcomes Research G (2018) An observational study of the efficacy of cisatracurium compared with vecuronium in patients with or at risk for acute respiratory distress syndrome. Am J Respir Crit Care Med 197:897\u2013904","journal-title":"Am J Respir Crit Care Med"}],"container-title":["Intensive Care Medicine Experimental"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40635-020-00348-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40635-020-00348-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40635-020-00348-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,22]],"date-time":"2021-10-22T19:16:49Z","timestamp":1634930209000},"score":1,"resource":{"primary":{"URL":"https:\/\/icm-experimental.springeropen.com\/articles\/10.1186\/s40635-020-00348-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,23]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["348"],"URL":"https:\/\/doi.org\/10.1186\/s40635-020-00348-6","relation":{},"ISSN":["2197-425X"],"issn-type":[{"value":"2197-425X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,23]]},"assertion":[{"value":"3 September 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"61"}}